LeonaBio, Inc.

US$4.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LONAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (45.74%)
Div yield —
ROE (431.39%)
Biotechnology
Beta (5Y) 1.92
PE TTM —
TSR TTM 6.26%
Mkt cap US$41.60M
ROIC (101.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.28
(2.95%)
(78.14%)
Hold 5|8|9|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.07
0.08
31.62%
26.51%
24.64%
18.62%
Revenue$M
2.128
2.196
2.268
2.397
12.02%
10.76%
13.37%
19.25%
Peers (US$41.60M)
Cap (US$)
PE
41.72M
—
40.84M
—
Capital
TTM
5Y
10Y
Leveragex
8.276
0.014
0.015
EBIT/Intx
0.490
0.532
0.456
Own earn%
42.23
(0.36)
12.03
Sh yield%
30.01
44.69
44.52
Owners
Insiders/Inst%
4.39
49.80
Short interest%
2.38
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
11–23
$1 testx
—
Incr. ROIC%
8